Benitec Biopharma (Contra CUSIP)
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BNIKF and buy or sell other stocks, ETFs, and their options commission-free!About BNIKF
Benitec Biopharma is using patented ‘gene-silencing’ technology to develop drugs for chronic and life-threatening human diseases. Their transformational technology, ddRNAi, targets and ‘turns off’ specific genes related to disease, providing lasting treatment and potentially cure with a single dose.
CEOJerel A. Banks, MD, PhD
CEOJerel A. Banks, MD, PhD
Employees—
Employees—
HeadquartersBalmain, New South Wales (NSW)
HeadquartersBalmain, New South Wales (NSW)
Founded1997
Founded1997
Employees—
Employees—
BNIKF Key Statistics
Market cap19.20M
Market cap19.20M
Price-Earnings ratio-0.93
Price-Earnings ratio-0.93
Dividend yield—
Dividend yield—
Average volume30.27K
Average volume30.27K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$10.49
52 Week high$10.49
52 Week low$1.90
52 Week low$1.90
Stock Snapshot
As of today, Benitec Biopharma (Contra CUSIP)(BNIKF) shares are valued at $2.35. The company's market cap stands at 19.2M, with a P/E ratio of -0.93.
Benitec Biopharma (Contra CUSIP)(BNIKF) stock opened on 2025-12-15 at —. The price climbed to — and dipped to —.
Benitec Biopharma (Contra CUSIP)(BNIKF) shares are trading with a volume of 0, against a daily average of 30.27K.
During the past year, Benitec Biopharma (Contra CUSIP)(BNIKF) stock moved between $1.90 at its lowest and $10.49 at its peak.
During the past year, Benitec Biopharma (Contra CUSIP)(BNIKF) stock moved between $1.90 at its lowest and $10.49 at its peak.